v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share Option Activity

A summary of the Company’s share option activity related to employees, non-employee members of the board of directors and non-employee consultants as of December 31, 2025 and for the six-month period ended June 30, 2026 is as follows (in thousands, except share and per share amounts):

Weighted-

  ​ ​ ​

  ​ ​ ​

Weighted-

  ​ ​ ​

Average

Average

Remaining

Number of

Exercise

Contractual

Options

Price

Term (years)

Outstanding at December 31, 2025

 

7,859,338

$

12.29

 

4.58

Granted

 

334,400

$

11.06

 

Exercised

 

(151,314)

$

5.76

 

Forfeited

 

(312,712)

$

14.55

 

Expired

(198,197)

$

7.72

Outstanding at June 30, 2026

 

7,531,515

$

12.51

4.56

Options exercisable at June 30, 2026

 

6,754,572

$

12.93

 

4.11

Options vested and expected to vest at June 30, 2026

7,531,515

$

12.51

4.56

Aggregate intrinsic value of options outstanding as of June 30, 2026

$

22,139

 

  ​

 

  ​

Aggregate intrinsic value of options exercisable as of June 30, 2026

$

19,361

 

  ​

 

  ​

Schedule of Inputs Used in Determining Fair Value of Share Options

  ​ ​ ​

2026

  ​ ​ ​

2025

Risk-free interest rate

 

4.20 - 4.21%

 

3.81 - 4.13%

Expected volatility

 

64%

 

67%

Expected dividend yield

 

0%

 

0%

Expected term (in years)

 

6.01

 

6.01

Schedule of Restricted Share Unit (RSU) Activity

  ​ ​ ​

  ​ ​ ​

Weighted-

Number of

Average

Restricted

Grant Date

Share Units

Fair Value

Outstanding at December 31, 2025

 

6,184,250

$

7.00

Granted

 

3,609,244

$

11.26

Vested

(1,939,250)

$

8.60

Forfeited

(8,000)

$

6.13

Outstanding at June 30, 2026

 

7,846,244

$

8.56

Schedule of Share-Based Compensation Expense

During the three-month and six-month periods ended June 30, 2026 and 2025, the Company recognized total share-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):

Three-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

956

$

2,091

General and administrative

 

2,823

3,573

Total share-based compensation

$

3,779

$

5,664

Six-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

1,928

$

4,139

General and administrative

 

5,505

6,412

Total share-based compensation

$

7,433

$

10,551

Employee Stock Option  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share-Based Compensation Expense

The Company recorded the following share-based compensation expense in connection with the options for the three-month and six-month periods ended June 30, 2026 and 2025 (in thousands):

Three-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

318

$

842

General and administrative

268

500

Total share-based compensation

$

586

$

1,342

Six-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

648

$

1,783

General and administrative

 

554

1,095

Total share-based compensation

$

1,202

$

2,878

Restricted share units  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share-Based Compensation Expense

The Company recorded the following share-based compensation expense in connection with the RSUs for the three-month and six-month periods ended June 30, 2026 and 2025 (in thousands):

Three-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

638

$

1,249

General and administrative

2,555

3,073

Total share-based compensation

$

3,193

$

4,322

Six-Month Periods Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

1,280

$

2,356

General and administrative

 

4,951

5,317

Total share-based compensation

$

6,231

$

7,673